• What are the pros and cons of the most implemented models?
• Exploring the various questions and contexts of use for each main model type and how translatable and clinically relevant they truly are
• How did you overcome hurdles encountered with your model when trying to better understand your drug/target?

Cell lines; In Vivo CDX, PDX, Transgenic, GEMMs; Ex Vivo/3D cultures; Computational/ In Silico